Literature DB >> 6403651

Synthetic Fc peptide-mediated regulation of the immune response. I. Characterization of the immunomodulating properties of a synthetic 23-amino acid peptide derived from the sequence of the CH3 domain of human IgG1.

E L Morgan, J E Shields, C S Campbell, R L Barton, G A Koppel, W O Weigle.   

Abstract

A synthetic 23-amino acid peptide derived from the CH3 domain of human IgG1 was found to be a potent adjuvant as well as a polyclonal activator. The Fc peptide was found to enhance human and murine humoral, and T cell-mediated immune responses. Moreover, in vivo administration of Fc peptide enhanced murine natural killer cell activity. The synthetic Fc peptide was found to be more potent, on a molar basis, than native Fc fragments in inducing polyclonal antibody production and potentiating immune responses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403651      PMCID: PMC2186970          DOI: 10.1084/jem.157.3.947

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Regulation of B lymphocyte activation by the Fc portion of immunoglobulin.

Authors:  E L Morgan; W O Weigle
Journal:  J Supramol Struct       Date:  1980

2.  Fc fragment activation of T lymphocytes. I. Fc fragments trigger Lyt 1+23- T lymphocytes to release a helper T cell-replacing activity.

Authors:  M L Thoman; E L Morgan; W O Weigle
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

3.  Enhancement of T. lymphocyte functions by Fc fragments of immunoglobulin. II. Augmentation of the cell-mediated lympholysis response occurs through an Lyt-1+2- helper T cell.

Authors:  E L Morgan; M L Thoman; W O Weigle
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

4.  Activation of human B lymphocytes XVI. Cellular requirements, interactions, and immunoregulation of pokeweed mitogen-induced total-immunoglobulin producing plaque-forming cells in peripheral blood.

Authors:  A S Fauci; G Whalen; C Burch
Journal:  Cell Immunol       Date:  1980-08-15       Impact factor: 4.868

5.  Regulation of the immune response. II. Characterization of the cell population(s) involved in the Fc fragment-induced adjuvant effect.

Authors:  E L Morgan; M L Thoman; S M Walker; W O Weigle
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

6.  Nature of the immunogenic moiety recognized by the human T cell proliferating in response to tetanus toxoid antigen.

Authors:  M D Broff; M E Jonsen; R S Geha
Journal:  Eur J Immunol       Date:  1981-05       Impact factor: 5.532

7.  Enhancement of T lymphocyte functions by Fc fragments of immunoglobulins. I. Augmentation of allogeneic mixed lymphocyte culture reactions requires I-A- or I-B-subregion differences between effector and stimulator cell populations.

Authors:  E L Morgan; M L Thoman; W O Weigle
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

8.  Polyclonal activation of human B lymphocytes by Fc fragments. I. Characterization of the cellular requirements for Fc fragment-mediated polyclonal antibody secretion by human peripheral blood B lymphocytes.

Authors:  E L Morgan; W O Weigle
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

9.  In vitro generation of antigen-specific hemolytic plaque-forming cells from human peripheral blood mononuclear cells.

Authors:  J Misiti; T A Waldmann
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

10.  Regulation of the immune response. I. The potentiation of in vivo and in vitro immune responses by Fc fragments.

Authors:  E L Morgan; S M Walker; M L Thoman; W O Weigle
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

View more
  2 in total

1.  Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.

Authors:  G M Bahr; D S Tello; L A Chedid
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

2.  Spontaneous and aggregated IgG induced rheumatoid factor producing cells in rheumatoid arthritis.

Authors:  E J Pisko; R A Turner; M Panetti; S L Foster; E Heise
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.